Cargando…

Initiation of antidepressants in patients infected with SARS-COV-2: Don't forget Caution for “Paradoxical” Anxiety/Jitteriness syndrome—Commentary: Prescription of selective serotonin reuptake inhibitors in COVID-19 infection needs caution

Detalles Bibliográficos
Autor principal: Bonnet, Udo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040771/
https://www.ncbi.nlm.nih.gov/pubmed/36993930
http://dx.doi.org/10.3389/fpsyt.2023.1095244
_version_ 1784912553637314560
author Bonnet, Udo
author_facet Bonnet, Udo
author_sort Bonnet, Udo
collection PubMed
description
format Online
Article
Text
id pubmed-10040771
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100407712023-03-28 Initiation of antidepressants in patients infected with SARS-COV-2: Don't forget Caution for “Paradoxical” Anxiety/Jitteriness syndrome—Commentary: Prescription of selective serotonin reuptake inhibitors in COVID-19 infection needs caution Bonnet, Udo Front Psychiatry Psychiatry Frontiers Media S.A. 2023-03-13 /pmc/articles/PMC10040771/ /pubmed/36993930 http://dx.doi.org/10.3389/fpsyt.2023.1095244 Text en Copyright © 2023 Bonnet. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Bonnet, Udo
Initiation of antidepressants in patients infected with SARS-COV-2: Don't forget Caution for “Paradoxical” Anxiety/Jitteriness syndrome—Commentary: Prescription of selective serotonin reuptake inhibitors in COVID-19 infection needs caution
title Initiation of antidepressants in patients infected with SARS-COV-2: Don't forget Caution for “Paradoxical” Anxiety/Jitteriness syndrome—Commentary: Prescription of selective serotonin reuptake inhibitors in COVID-19 infection needs caution
title_full Initiation of antidepressants in patients infected with SARS-COV-2: Don't forget Caution for “Paradoxical” Anxiety/Jitteriness syndrome—Commentary: Prescription of selective serotonin reuptake inhibitors in COVID-19 infection needs caution
title_fullStr Initiation of antidepressants in patients infected with SARS-COV-2: Don't forget Caution for “Paradoxical” Anxiety/Jitteriness syndrome—Commentary: Prescription of selective serotonin reuptake inhibitors in COVID-19 infection needs caution
title_full_unstemmed Initiation of antidepressants in patients infected with SARS-COV-2: Don't forget Caution for “Paradoxical” Anxiety/Jitteriness syndrome—Commentary: Prescription of selective serotonin reuptake inhibitors in COVID-19 infection needs caution
title_short Initiation of antidepressants in patients infected with SARS-COV-2: Don't forget Caution for “Paradoxical” Anxiety/Jitteriness syndrome—Commentary: Prescription of selective serotonin reuptake inhibitors in COVID-19 infection needs caution
title_sort initiation of antidepressants in patients infected with sars-cov-2: don't forget caution for “paradoxical” anxiety/jitteriness syndrome—commentary: prescription of selective serotonin reuptake inhibitors in covid-19 infection needs caution
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040771/
https://www.ncbi.nlm.nih.gov/pubmed/36993930
http://dx.doi.org/10.3389/fpsyt.2023.1095244
work_keys_str_mv AT bonnetudo initiationofantidepressantsinpatientsinfectedwithsarscov2dontforgetcautionforparadoxicalanxietyjitterinesssyndromecommentaryprescriptionofselectiveserotoninreuptakeinhibitorsincovid19infectionneedscaution